MedPath

Comparison of local versus systemic tranexamic acid in total knee replacement

Completed
Conditions
Primary osteoarthritis knee
Registration Number
CTRI/2017/04/008401
Lead Sponsor
Sri Sathya Sai Institute of Higher Medical Sciences Prasanthigram
Brief Summary

This study is intended to test for equivalence between intraarticular and intravenous routes for administration of tranexamic acid for control of perioperative blood loss in total knee replacement in terms of efficacy and safety.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
138
Inclusion Criteria
  • All patients undergoing total knee arthroplasty for primary arthroplasty knee 2.Patients who are willing to participate in the study.
  • 3.Patient without exclusion criteria.
Exclusion Criteria
  • 1.Allergy to the TXA 2.H/O Coagulopathy,abnormal PT or APTT 3.Past H/O Thromboembolic event 4.Treatment with Aspirin or NSAIDS in the last week 5.plasma creatinine > 115 micro moles /litre for males And >100 micro moles/litre in females.
  • 6.Acute infection[eg;leukocytosis or fever] 7.Malignancy 8.MI in preceding 12 months,unstable angina 9.Patient who were given plasma in perioperative period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative Hemoglobon dropAssessed at 5 days of surgery
Secondary Outcome Measures
NameTimeMethod
Perioperative blood loss, need for post operative blood transfusion, impairment of renal function, occurrence of deep vein thrombosis6 weeks

Trial Locations

Locations (1)

Sri Sathya Sai Institute of Higher Medical Sciences - Prasanthigram

🇮🇳

Anantapur, ANDHRA PRADESH, India

Sri Sathya Sai Institute of Higher Medical Sciences - Prasanthigram
🇮🇳Anantapur, ANDHRA PRADESH, India
Dr Koushik Narayan Subramanyam
Principal investigator
9491629620
drkoushik@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.